Sinovac eyes 2bln doses in annual capacity of virus vaccine by June

The figure is double its previous yearly capacity of 1bln doses

  
A box with China's SINOVAC vaccines against the coronavirus disease (COVID-19) is seen during the first stage of the vaccination plan, which aims to inoculate teachers, military personnel, firefighters and police officers, among other non medical essential workers, at a vaccination center in Antel Arena, Montevideo, Uruguay March 1, 2021.

A box with China's SINOVAC vaccines against the coronavirus disease (COVID-19) is seen during the first stage of the vaccination plan, which aims to inoculate teachers, military personnel, firefighters and police officers, among other non medical essential workers, at a vaccination center in Antel Arena, Montevideo, Uruguay March 1, 2021.

REUTERS/Mariana Greif

BEIJING - Sinovac Biotech's annual production capacity of COVID-19 vaccine can reach 2 billion doses by June, a company spokesman confirmed to Reuters on Wednesday.

The figure is double its previous yearly capacity of 1 billion doses in the form of bulk ingredient which the firm had said it could reach by February.

State media the Global Times had first reported the news, citing a comment from the firm's chief executive.

(Reporting by Roxanne Liu, Lusha Zhang and Ryan Woo; Editing by Clarence Fernandez) ((hongkong.newsroom@thomsonreuters.com; (8610)6627-1277; Reuters Messaging: roxanne.liu@thomsonreuters.com))

More From Business